Latest news - Novo Nordisk
WEBAug 6, 2024 — Latest news. 20 September 2024. Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed. Read more. 19 September 2024. Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function. Read more. 06 …
Novo Nordisk has mitigation plans to minimize disruption from …
WEB1 day ago — NVO. (Reuters) -Danish drugmaker Novo Nordisk said on Tuesday it has mitigation plans in place to minimize or prevent any disruption to its production due to sea port strikes in the United States ...
Novo Nordisk has mitigation plans to minimize disruption from …
WEB1 day ago — Danish drugmaker Novo Nordisk has mitigation plans in place to minimize or prevent any disruption to its production due to sea port strikes in the United States, CNBC reported on Tuesday citing a ...
Novo Nordisk Just Committed More Than $1.1 Billion to Make …
WEB6 days ago — In mid-September, Novo Nordisk inked a pair of deals worth a total of more than $1.1 billion in research and development (R&D) costs, payments, milestone fees, and royalties, with the explicit aim ...
Company announcements and press releases - Novo Nordisk
WEBNovo Nordisk to present new data from key diabetes and obesity trials at the 60th annual meeting of the European Association for the Study of Diabetes. Novo Nordisk's sales increased by 24% in Danish kroner and by 25% at constant exchange rates to DKK 133.4 billion in the first six months of 2024.
Novo Nordisk CEO testifies at Senate over weight loss drug prices
WEBSep 24, 2024 — Novo Nordisk’s top executive faced a Senate grilling over the high prices of the company’s weight loss drug Wegovy and diabetes treatment Ozempic. The Danish drugmaker’s CEO, Lars Fruergaard ...
Novo Nordisk faces US congressional grilling over price of weight …
WEBSep 23, 2024 — Novo Nordisk's chief executive is preparing for a showdown next week with U.S. Senator Bernie Sanders over the high price of blockbuster diabetes and weight loss drugs, as Ozempic falls into the ...
Novo Nordisk to build $4.1 billion North Carolina facility to boost ...
WEBJun 24, 2024 — Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy,...
News & media - Novo Nordisk
WEBGet an overview of the Novo Nordisk press releases here or subscribe to our news and get it directly in your mailbox when we have news to tell.
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy …
WEBApr 20, 2024 — Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions.
- Some results have been removed